PI3KC2β: A promising therapeutic target in myotubular myopathy

被引：0

作者：

Goret, Marie ^{[1
]}

Massana-Munoz, Xenia ^{[1
]}

Nattarayan, Vasugi ^{[1
]}

Reiss, David ^{[1
]}

Laporte, Jocelyn ^{[1
]}

机构：

[1] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire IGBMC, INSERM U1258, CNRS UMR7104, Illkirch Graffenstaden, France

来源：

M S-MEDECINE SCIENCES | 2023年 / 39卷

关键词：

D O I：

10.1051/medsci/2023134

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Myotubular myopathy is a rare disease of genetic origin characterized by significant muscle weakness leading to respiratory disorders and for which no treatment exists today. In this paper, we show that inhibition of the activity of the enzyme PI3KC2 beta prevents the development of this myopathy in a mouse model of the disease, thus identifying a therapeutic target to treat myotubular myopathy in humans.

引用

页码：32 / 36

页数：5

共 50 条

[11] PI3KC2α, a class II PI3K, is required for dynamin-independent internalization pathways
Salcini, A. E.
FEBS JOURNAL, 2010, 277 : 26 - 27
[12] PI3KC2α, a class II PI3K, is required for dynamin-independent internalization pathways
Krag, Claudia
Malmberg, Emily Kim
Salcini, Anna Elisabetta
JOURNAL OF CELL SCIENCE, 2010, 123 (24) : 4240 - 4250
[13] Phosphatidylinositol 3-kinase, class 2 beta (PI3KC2β) isoform contributes to neuroblastoma tumorigenesis
Russo, Angela
Okur, Mustafa Nazir
Bosland, Maarten
O'Bryan, John P.
CANCER LETTERS, 2015, 359 (02) : 262 - 268
[14] PI3KC2α controls cardiac contractility through regulation of β2-adrenergic receptor recycling
Cnudde, Sophie
Brand, Theresa
Fender, Julia
Prever, Lorenzo
Murabito, Alessandra
Russo, Michele
Logrand, Federica
Gulluni, Federico
Lorenz, Kristina
Hirsch, Emilio
Ghigo, Alessandra
VASCULAR PHARMACOLOGY, 2024, 155 : 107313
[15] PI3KC2β inactivation stabilizes VE-cadherin junctions and preserves vascular integrity
Anquetil, Typhaine
Solinhac, Romain
Jaffre, Aude
Chicanne, Gaetan
Viaud, Julien
Darcourt, Jean
Orset, Cyrille
Geuss, Eva
Kleinschnitz, Christoph
Vanhaesebroeck, Bart
Vivien, Denis
Hnia, Karim
Larrue, Vincent
Payrastre, Bernard
Gratacap, Marie-Pierre
EMBO REPORTS, 2021, 22 (06)
[16] Decrease the expression of dynamin 2 A therapeutic track in the myotubular myopathy?
Laporte, Jocelyn
Cowling, Belinda
M S-MEDECINE SCIENCES, 2014, 30 (6-7): : 621 - 624
[17] The PI 3-kinase PI3KC2α regulates mouse platelet membrane structure and function independently of membrane lipid composition
Selvadurai, Maria V.
Brazilek, Rose J.
Moon, Mitchell J.
Rinckel, Jean-Yves
Eckly, Anita
Gachet, Christian
Meikle, Peter J.
Nandurkar, Harshal H.
Nesbitt, Warwick S.
Hamilton, Justin R.
FEBS LETTERS, 2019, 593 (01): : 88 - 96
[18] Calcium influx mediated by FcεRI in RBL-2H3 mast cells overexpressing PI3KC2β.
Clemons, TAM
Lee, HS
Choi, OH
FASEB JOURNAL, 2001, 15 (04): : A201 - A201
[19] Republication: Targeting PI3KC2? Impairs Proliferation and Survival in Acute Leukemia, Brain Tumours and Neuroendocrine Tumours
Boller, Danielle
Doepfner, Kathrin T.
De Laurentiis, Angela
Guerreiro, Ana S.
Marinov, Marin
Shalaby, Tarek
Depledge, Paul
Robson, Anthony
Saghir, Nahid
Hayakawa, Masahiko
Kaizawa, Hiroyuki
Koizumi, Tomonobu
Ohishi, Takahide
Fattet, Sarah
Delattre, Olivier
Schweri-Olac, Anelia
Hoeland, Katrin
Grotzer, Michael A.
Frei, Karl
Spertini, Olivier
Waterfield, Michael D.
Arcaro, Alexandre
ANTICANCER RESEARCH, 2022, 42 (06) : 3217 - 3230
[20] PI3KC2α regulates cardiac contractility by restraining the β-adrenergic receptor/cyclic AMP (β-AR/cAMP) pathway
Cnudde, Sophie
Russo, Michele
Prever, Lorenzo
Fuentes, Susana
Murabito, Alessandra
Logrand, Federica
Fagoonee, Sharmila
Gulluni, Federico
Hirsch, Emilio
Ghigo, Alessandra
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2022, 173 : S137 - S138

← 1 2 3 4 5 →